Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07659548

Home-based Monitoring & Enabled Medication Independence With New Digital Tools

This clinical trial is studying an online tool that may help older adults safely manage their medications at home. The study focuses on older adults who live alone and have memory concerns or mild changes in thinking. Many people in this group take several medications, which can make it hard to keep track of when and how to take them, notice side effects, or know when to ask for help.

In this study, participants use an online self-monitoring platform to record any problems, symptoms, or concerns they have while taking their medications. The platform also provides helpful education and suggestions for managing medications and symptoms. Participants can share summaries from the platform with their health care team, which may help improve communication and support.

The goal of the study is to see whether this tool can help older adults feel more confident, informed, and prepared to manage their medications safely while living at home.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Older Adults (65 Years and Older) Living Alone Mild Cognitive Decline Polypharmacy (People Under Treatment With 5 or More Drugs)

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The main goal of this study is to find out whether an online self-monitoring tool can help older adults who live alone and have memory concerns or mild changes in thinking manage their medications more safely and easily.

The study will look at whether the tool helps people: (1) take their medications as prescribed; (2) keep track of medication-related problems or concerns; (3) feel more confident managing medications at home; and (4) reduce stress, confusion, or burden that can come with taking multiple medications.

Other Study Goal:

The study will also explore whether older adults are willing and able to use the online tool regularly to track medication safety concerns in their daily lives. This includes looking at how comfortable participants feel using the tool and whether they find it helpful for monitoring their medications, symptoms, and concerns.

What Will Happen in the Study:

Participants will be randomly assigned - like flipping a coin - to one of two groups:

Group 1: Online Tool Group:

Participants in this group will receive training on how to use the online self-monitoring tool. They will use the tool for 3 months to track medication-related problems, symptoms, side effects, or other concerns while at home.

During this time, participants will also (1) receive monthly check-ins about their experience using the tool; (2) get educational information and suggestions based on what they report; (3) receive summaries of their medication self-monitoring journey; and (4) be able to interact with an online chatbot about their medication-related concerns.

Group 2: Usual Care Group:

Participants in this group will continue following their regular medical care and medication instructions for the first 3 months.

During this time, they will complete monthly follow-up assessments with the study team. After the first 3 months, they will have the opportunity to use the online self-monitoring tool for 1 month.

Overall Purpose:

By comparing these two groups, researchers hope to learn whether the online tool is useful, easy to use, and helpful for supporting safer medication management among older adults living alone with memory concerns or mild thinking changes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older adults (≥ 65 years old)
  • Living alone (in a non-institutional setting without others)
  • With subjective or mild cognitive decline (a screening test to confirm)
  • Taking at least five prescribed medications concurrently
  • With suboptimal self-reported medication adherence (a screening test to confirm)
  • Having access to a computer or mobile device and internet service
  • Able to read and speak English

Exclusion criteria

  • Having severe cognitive, vision, hearing, or other impairment
  • Unable to use computers or mobile devices
  • Relying on someone else to manage medications

Treatment and study plan

HOME-MIND

Behavioral

HOME-MIND aims to improve medication self-management and reduce perceived medication burden in older adults living alone with subjective or mild cognitive decline. This 3-month intervention includes daily technology-enabled self-monitoring of medication safety events or experiences, personalized educational support informed by self-monitoring data, visualizations and summaries of self-monitoring data on a personal dashboard, and sharing self-monitoring summaries with health care providers to facilitate health communication.

Primary outcomes

  1. Medication self-management

    Time frame: From enrollment to the end of the study at 3 months, including monthly assessments.

    Medication self-management is defined as "the extent to which a patient takes medication as prescribed, including not only the correct dose, frequency and spacing, but also its continued, safe use over time". It is deconstructed into a series of steps a patient must take to safely and effectively take their medications, including filling a prescription, understanding directions for use, organizing a regimen, taking medications, monitoring side effects, and sustaining use over time. In this study, medication self-management will be measured using the 12-item Measure of Drug Self-Management.

Secondary outcomes

  1. Medication burden

    Time frame: From enrollment to the end of the study at 3 months, it was assessed at baseline and at 3 months.

    Assessing patient-perceived medication burden is the first step in medication optimization and evaluates how complex dosing regimens, side effects, out-of-pocket costs, and daily lifestyle disruptions affect a patient's quality of life, helping determine patients' attitudes toward and experiences with medications. In this study, perceived medication burden is measured using the 41-item Living with Medicines Questionnaire (LMQ-3), which includes eight domains: relationships with health professionals, practicalities, interferences, effectiveness, side effects, concerns, cost, and autonomy.

Other outcomes

  1. Patient activation

    Time frame: From enrollment to the end of the study at 3 months, including monthly assessments.

    Patient activation refers to an individual's confidence, knowledge, motivation, and skills integral to managing one's own health and healthcare, measured by the 13-item Patient Activation Measure (PAM).

Study contacts

Contact information is provided by the study sponsor or research team.

Chelsea Frank, BS, MBA

CONTACT

[email protected]

734-647-4710

Yun Jiang, PhD, MS, RN

CONTACT

[email protected]

734-763-3705

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • Arizona State University
  • National Institute on Aging (NIA)

Registry information

Official study title

Technological Innovation to Support Medication Safety and Optimization in Older Adults Living Alone With Cognitive Decline

Acronym: HOME-MIND

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Jun 22, 2026
Registry last updated
Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.